Key Points
- Insight Holdings Group, Hinge Health’s major shareholder, sold 181,499 shares on July 9 for about $16.37 million at an average price of $90.20.
- The sale is part of a recent streak of insider selling by Insight Holdings, including several large transactions in late June and early July.
- Hinge Health’s stock was trading near its 52-week high at $89.95, and the company recently beat quarterly EPS estimates while posting 47.2% revenue growth year over year.
Hinge Health Inc. (NYSE:HNGE - Get Free Report) major shareholder Insight Holdings Group, Llc sold 181,499 shares of the business's stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $90.20, for a total transaction of $16,371,209.80. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Insight Holdings Group, Llc also recently made the following trade(s):
- On Tuesday, July 7th, Insight Holdings Group, Llc sold 244,672 shares of Hinge Health stock. The stock was sold at an average price of $90.23, for a total transaction of $22,076,754.56.
- On Thursday, June 25th, Insight Holdings Group, Llc sold 530,982 shares of Hinge Health stock. The shares were sold at an average price of $71.82, for a total transaction of $38,135,127.24.
- On Monday, June 29th, Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock. The stock was sold at an average price of $82.83, for a total transaction of $121,484,027.61.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The stock was sold at an average price of $71.67, for a total value of $10,199,429.37.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total value of $27,813,744.55.
- On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The stock was sold at an average price of $70.21, for a total transaction of $7,897,010.17.
- On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total value of $15,921,109.05.
- On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The shares were sold at an average price of $70.36, for a total value of $4,614,279.16.
Hinge Health Trading Up 1.6%
Shares of NYSE HNGE opened at $89.95 on Friday. The company has a market capitalization of $6.96 billion, a price-to-earnings ratio of -7.29 and a beta of 1.13. Hinge Health Inc. has a twelve month low of $30.08 and a twelve month high of $91.07. The firm has a 50-day moving average of $64.48 and a two-hundred day moving average of $49.91.
Hinge Health (NYSE:HNGE - Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.33. The firm had revenue of $182.31 million for the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The company's quarterly revenue was up 47.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.30 EPS. As a group, research analysts predict that Hinge Health Inc. will post 1.33 earnings per share for the current year.
Institutional Trading of Hinge Health
A number of hedge funds have recently made changes to their positions in the stock. Vista Investment Partners LLC acquired a new stake in shares of Hinge Health during the second quarter worth approximately $3,468,000. Assenagon Asset Management S.A. acquired a new position in Hinge Health in the 2nd quarter valued at approximately $6,867,000. California State Teachers Retirement System lifted its position in Hinge Health by 35.2% in the 1st quarter. California State Teachers Retirement System now owns 19,141 shares of the company's stock worth $738,000 after buying an additional 4,986 shares in the last quarter. Estuary Capital Management LP purchased a new stake in Hinge Health in the 1st quarter worth approximately $15,201,000. Finally, Lazard Asset Management LLC boosted its stake in shares of Hinge Health by 0.6% during the 1st quarter. Lazard Asset Management LLC now owns 63,705 shares of the company's stock valued at $2,456,000 after buying an additional 386 shares during the period.
Analyst Ratings Changes
Several equities research analysts have recently commented on HNGE shares. Evercore reaffirmed an "outperform" rating and set a $45.00 target price on shares of Hinge Health in a report on Wednesday, April 8th. Citizens Jmp lifted their price target on Hinge Health from $65.00 to $80.00 and gave the stock a "market outperform" rating in a research note on Wednesday, May 6th. Wall Street Zen lowered shares of Hinge Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, June 6th. Weiss Ratings upgraded shares of Hinge Health from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, May 6th. Finally, Zacks Research raised shares of Hinge Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, May 13th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $75.80.
Check Out Our Latest Analysis on HNGE
Hinge Health Company Profile
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
